Apr 242018
 

By Talent4Boards Team

Talent4Boards - Great Talent builds Great Boards

– USA, PA – Aclaris Therapeutics, Inc. (NASDAQ:ACRS), a dermatologist-led biopharmaceutical company committed to identifying, developing, and commercializing innovative therapies to address significant unmet needs in aesthetic and medical dermatology and immunology, today announced the appointment of Bryan Reasons as a director and Chairman of the Audit Committee.… => Read full post

Aclaris Therapeutics appoints Bryan Reasons to the Board of Directors and its Audit Committee

From:: Aclaris Therapeutics appoints Bryan Reasons to the Board of Directors and its Audit Committee

Sorry, the comment form is closed at this time.

%d bloggers like this: